Literature DB >> 11006017

Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1-like protease.

E J Chung1, S H Choi, Y H Shim, Y J Bang, K C Hur, C W Kim.   

Abstract

Transforming growth factor-beta (TGF-beta) has been known as a potent immunosuppressive cytokine that can induce apoptosis in lymphoid cells. We established an IL-2-independent cell line, CTLL-2A, from murine T cell line CTLL-2. CTLL-2A expressed higher levels of CD95, CD69, and CD18 molecules than CTLL-2 did, suggesting a more activated state in CTLL-2A than in the CTLL-2 by phenotype. Exposing both CTLL-2 and CTLL-2A to TGF-beta results in differential apoptosis patterns defined by DNA fragmentation and plasma membrane alteration. Among the bcl-2 family members, bcl-2, bcl-w, and bcl-x(L) were also differently expressed in these two cell lines. In CTLL-2A, bcl-x(L) was amplified as a major anti-apoptotic molecule, and TGF-beta-induced cell death was more enhanced than in the original cell line. Caspase 1-like protease was activated by TGF-beta treatment and consequently it cleaved bcl-x(L) in CTLL-2A. TGF-beta-induced DNA fragmentation and cleavage of bcl-x(L) were inhibited by pretreatment with tetra peptide caspase 1 inhibitor, YVAD.cmk. These findings suggest that TGF-beta induces cell death in activated murine T cells through cleavage of bcl-x(L) via activated caspase 1-like protease, which may act as an important executor in that process. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006017     DOI: 10.1006/cimm.2000.1694

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

Review 1.  TGF-beta, T-cell tolerance and anti-CD3 therapy.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

2.  Influence of gangliosides on the IL-2- and IL-4-dependent cell proliferation.

Authors:  Irina M Molotkovskaya; Roman V Kholodenko; Julian G Molotkovsky
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

4.  TGF-beta and regulatory T cell in immunity and autoimmunity.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Clin Immunol       Date:  2008-09-16       Impact factor: 8.317

Review 5.  The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.

Authors:  David A Horwitz; J Dixon Gray; Song Guo Zheng
Journal:  Arthritis Res       Date:  2002-03-12

Review 6.  The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets.

Authors:  David A Horwitz; Song Guo Zheng; J Dixon Gray
Journal:  J Leukoc Biol       Date:  2003-10       Impact factor: 4.962

Review 7.  'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.